Dr. Natalya Lyubynska, MD

Dr. Lyubynska practices at Cleveland Clinic Indian River Hospital in Vero Beach, Florida, part of The Cleveland Clinic Foundation.

Dr. Lyubynska's NPI, 1932410511, was assigned on June 29, 2010. Dr. Lyubynska graduated from UCSF School of Medicine in 2010. Dr. Lyubynska holds Florida license ME 115759.

Dr. Lyubynska's primary practice is Cleveland Clinic Indian River Hospital, at 1000 36th St, Vero Beach, FL 32960 in Indian River County. The practice phone is (772) 567-4311.

Dr. Lyubynska's primary practice is Cleveland Clinic Indian River Hospital in Vero Beach, Florida, part of The Cleveland Clinic Foundation. Dr. Lyubynska is also affiliated with Grandview Medical Center. The medical group on file is Cleveland Clinic Indian River Hospital. Dmand AI also links Dr. Lyubynska to 2 more hospitals, 9 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lyubynska practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Lyubynska's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Lyubynska is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Lyubynska's licenses on file in 3 states: Florida, Alabama and Michigan.

Dmand AI lists acute diabetes, acute respiratory failure, acute stomach ulcer, anemia, atherosclerosis, cardiac arrhythmia, chest pain and circulation problems among the conditions Dr. Lyubynska treats.

CMS data shows 1,021 Medicare services from Dr. Lyubynska across 5 procedure codes in 2024, for 377 Medicare patients. Medicare paid $85,781 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 377 Medicare patients who saw Dr. Lyubynska in 2024. The largest group is 75 to 84, with 133 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lyubynska's median patient age at 70, with 53% women.

In 2024, Dr. Lyubynska wrote 494 Medicare Part D claims for 161 patients. 87% of them were for generic drugs. CMS names the drug for 226 of them, across 11 drugs with 11 or more claims each, at $14,565 in total drug cost. In 2023, CMS named 77 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 25 out of 100 for Dr. Lyubynska for performance year 2024, reported individually. Dr. Lyubynska accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Lyubynska in 2017. Dr. Lyubynska's most frequent co-authors are Benjamin S. Braun, MD, Matthew Francis Gorman, MD and Wan Xing Hong.

CMS Open Payments shows 108 general payments to Dr. Lyubynska from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,057.

Dr. Lyubynska graduated from UCSF School of Medicine in 2010.

Dr. Lyubynska is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.